GeneDx Holdings Corp (WGS)
19.76
+0.26
(+1.36%)
USD |
NASDAQ |
May 03, 16:00
19.76
0.00 (0.00%)
After-Hours: 20:00
GeneDx Holdings Shareholders Equity (Quarterly): 207.22M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 207.22M |
December 31, 2023 | 228.02M |
September 30, 2023 | 254.26M |
June 30, 2023 | 296.11M |
March 31, 2023 | 328.47M |
December 31, 2022 | 253.70M |
Date | Value |
---|---|
September 30, 2022 | 561.29M |
June 30, 2022 | 637.27M |
March 31, 2022 | 329.44M |
December 31, 2021 | 388.10M |
September 30, 2021 | 391.26M |
December 31, 2020 | -330.05M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-330.05M
Minimum
Dec 2020
637.27M
Maximum
Jun 2022
295.43M
Average
312.29M
Median
Shareholders Equity (Quarterly) Benchmarks
American Well Corp | 464.22M |
GoodRx Holdings Inc | 761.96M |
Privia Health Group Inc | 561.44M |
Doximity Inc | 864.61M |
GE HealthCare Technologies Inc | 7.408B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 394.53M |
Total Liabilities (Quarterly) | 187.31M |
Debt to Equity Ratio | 0.2524 |
Current Ratio | 3.221 |
Net Debt Paydown Yield | -3.46% |